Literature DB >> 25755540

Shortcut route for generation of functional hepatocyte cells from human skin allogenically for autologous treatment of chronic liver diseases.

Shibashish Giri1, Augustinus Bader1.   

Abstract

Entities:  

Keywords:  human adult hepatocyte; iPS, induced pluripotent stem cells; induced pluripotent stem cells; in vivo reprogramming; small molecules; transcription factors

Year:  2014        PMID： 25755540      PMCID： PMC4188835          DOI： 10.1016/j.jceh.2014.03.051

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  15 in total

1.  Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors.

Authors:  Sayaka Sekiya; Atsushi Suzuki
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

2.  Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice.

Authors:  Y Chen; J Li; X Liu; W Zhao; Y Wang; X Wang
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

3.  Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation.

Authors:  Bruno Gridelli; Giovanni Vizzini; Giada Pietrosi; Angelo Luca; Marco Spada; Salvatore Gruttadauria; Davide Cintorino; Giandomenico Amico; Cinzia Chinnici; Toshio Miki; Eva Schmelzer; Pier Giulio Conaldi; Fabio Triolo; Jörg C Gerlach
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.

Authors:  Pengyu Huang; Ludi Zhang; Yimeng Gao; Zhiying He; Dan Yao; Zhitao Wu; Jin Cen; Xiaotao Chen; Changcheng Liu; Yiping Hu; Dongmei Lai; Zhenlei Hu; Li Chen; Ying Zhang; Xin Cheng; Xiaojun Ma; Guoyu Pan; Xin Wang; Lijian Hui
Journal:  Cell Stem Cell       Date:  2014-02-27       Impact factor: 24.633

6.  Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.

Authors:  X Hu; T Yang; C Li; L Zhang; M Li; W Huang; P Zhou
Journal:  Transplant Proc       Date:  2013-03       Impact factor: 1.066

7.  Human fetal hepatocyte transplantation in patients with fulminant hepatic failure.

Authors:  C M Habibullah; I H Syed; A Qamar; Z Taher-Uz
Journal:  Transplantation       Date:  1994-10-27       Impact factor: 4.939

8.  Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.

Authors:  Hisaya Azuma; Nicole Paulk; Aarati Ranade; Craig Dorrell; Muhsen Al-Dhalimy; Ewa Ellis; Stephen Strom; Mark A Kay; Milton Finegold; Markus Grompe
Journal:  Nat Biotechnol       Date:  2007-07-29       Impact factor: 54.908

9.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Authors:  Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

10.  Mouse liver repopulation with hepatocytes generated from human fibroblasts.

Authors:  Saiyong Zhu; Milad Rezvani; Jack Harbell; Aras N Mattis; Alan R Wolfe; Leslie Z Benet; Holger Willenbring; Sheng Ding
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962
View more
  2 in total

1.  A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.

Authors:  Afshan N Malik; Inês C M Simões; Hannah S Rosa; Safa Khan; Agnieszka Karkucinska-Wieckowska; Mariusz R Wieckowski
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

2.  Contribution of dermal-derived mesenchymal cells during liver repair in two different experimental models.

Authors:  Li Tan; Tingyu Dai; Dengqun Liu; Zelin Chen; Liao Wu; Li Gao; Yu Wang; Chunmeng Shi
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.